147 related articles for article (PubMed ID: 4010793)
1. Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.
Dupont AG; Lefebvre RA; Bogaert MG
Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):146-51. PubMed ID: 4010793
[TBL] [Abstract][Full Text] [Related]
2. Effect of bromocriptine on neurogenic vasoconstriction in the isolated autoperfused hindquarters of the rat.
Roquebert J; Alaoui K; Morán A
Fundam Clin Pharmacol; 1990; 4(5):539-45. PubMed ID: 2289745
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of peripheral neuronal dopamine receptors in the rat.
Dupont AG; Lefebvre RA; Bogaert MG
Clin Exp Hypertens A; 1987; 9(5-6):913-29. PubMed ID: 2887314
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of noradrenergic neurotransmission by apomorphine and pergolide in the in situ autoperfused rat renal and superior mesenteric vascular beds.
Dupont AG; Lefebvre RA; Bogaert MG
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):229-34. PubMed ID: 3020437
[TBL] [Abstract][Full Text] [Related]
5. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
Dupont AG; Lefebvre RA; Vanderniepen P
Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
[TBL] [Abstract][Full Text] [Related]
6. Effect of quinpirole on neurogenic vasoconstriction in the in situ autoperfused hindquarters and renal vascular beds of the rat.
Roquebert J; Moran A; Demichel P
J Auton Pharmacol; 1992 Oct; 12(5):291-8. PubMed ID: 1358890
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Lokhandwala MF; Kivlighn SD; Jandhyala BS
J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
10. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.
Herrera-Marschitz M; Ungerstedt U
Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675
[TBL] [Abstract][Full Text] [Related]
11. Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia.
Bergstrom DA; Bromley SD; Walters JR
Eur J Pharmacol; 1984 Apr; 100(1):3-12. PubMed ID: 6723776
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1982 Jan; 77(1):79-83. PubMed ID: 6277657
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of neuronal dopamine receptors in the rat hindquarters, renal and superior mesenteric vascular beds.
Dupont AG; Vanderniepen P; Lefebvre RA; Bogaert MG
J Auton Pharmacol; 1986 Dec; 6(4):305-9. PubMed ID: 2950101
[TBL] [Abstract][Full Text] [Related]
14. Effects of pergolide, a dopamine receptor agonist, and clonidine on cardiovascular responses evoked by activation of peripheral sympathetic outflow in rats.
Cavero I
Clin Exp Hypertens A; 1982; 4(1-2):221-33. PubMed ID: 7074987
[TBL] [Abstract][Full Text] [Related]
15. Effect of co-dergocrine in the autoperfused superior mesenteric vascular bed of the rat.
Lefebvre RA; Devreese K
J Auton Pharmacol; 1991 Jun; 11(3):155-65. PubMed ID: 1649194
[TBL] [Abstract][Full Text] [Related]
16. Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide.
Fuller RW; Perry KW; Hemrick-Luecke SK
Neurochem Res; 1982 Apr; 7(4):399-405. PubMed ID: 6125905
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
Hietala J; MacDonald E; Scheinin M
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):291-7. PubMed ID: 3799208
[TBL] [Abstract][Full Text] [Related]
18. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
Suaud-Chagny MF; Ponec J; Gonon F
Neuroscience; 1991; 45(3):641-52. PubMed ID: 1775239
[TBL] [Abstract][Full Text] [Related]
20. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
